Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.08% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Mar 31, 2025
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-25-003701General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-19.25% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
18.04% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
133.21% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
30.67% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-14.56% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.42% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 4.75%
- Current
- 0.08%
- Delta
- -4.67%
- Previous
- -35.93%
- Current
- -19.25%
- Delta
- 16.68%
- Previous
- 44.75%
- Current
- 18.04%
- Delta
- -26.71%
- Previous
- 32.34%
- Current
- 133.21%
- Delta
- 100.87%
- Previous
- 30.59%
- Current
- 30.67%
- Delta
- 0.08%
- Previous
- -16.67%
- Current
- -14.56%
- Delta
- 2.11%
- Previous
- 2.68%
- Current
- 2.42%
- Delta
- -0.26%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBFM Fundamental State →Analogous To · SBFM state analogue 1 →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CAPEX_INTENSITY_DECREASED →Transitioned To · SBFM CASH_GENERATION_INCREASED →Transitioned To · SBFM GROWTH_DECREASED →Transitioned To · SBFM INVENTORY_PRESSURE_INCREASED →Transitioned To · SBFM MARGIN_INCREASED →Transitioned To · SBFM PROFITABILITY_INCREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.